JOSEPH RICCI: Open Payments
NPI 1649685280 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,525 in 74 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $760 · 2025 $1,525
Food & beverage: $1,425Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $325 |
| ABBVIE INC. | 13 | $255 |
| UCB, Inc. | 10 | $159 |
| Regeneron Healthcare Solutions, Inc. | 6 | $139 |
| Organon LLC | 6 | $86 |
| Incyte Corporation | 3 | $85 |
| Arcutis Biotherapeutics, Inc. | 3 | $77 |
| Galderma Laboratories, L.P. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| LEO Pharma Inc. | 2 | $51 |
Products named: TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, RINVOQ, OPZELURA, Zoryve, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
